# Genenta Science S.p.A. (SAEN)

Source: https://www.quantisnow.com/company/SAEN
Generated: 2026-11-11T22:32:20.752Z

- Ticker: SAEN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- IPO year: 2021
- SEC CIK: 0001838716
- Website: https://www.genenta.com

## About

Genenta Science (Nasdaq: GNTA) is evolving into a next-generation strategic consolidator focused on privately held specialized companies operating in Italian national security-regulated sectors, with activities spanning cybersecurity, defense, aerospace, and biotechnology/biosecurity. Genenta holds a 19% equity interest in Sòphia High Tech and has an option to increase its ownership to 51% at a pre-agreed valuation.

## Latest SAEN news and filings

No events on the wire yet.

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SAEN
- Earnings history: https://www.quantisnow.com/earnings/SAEN
- Dividend history: https://www.quantisnow.com/dividends/SAEN
- Insider transactions: https://www.quantisnow.com/insiders/SAEN
- Options chain: https://www.quantisnow.com/options/SAEN
- SEC 8-K filings only: https://www.quantisnow.com/company/SAEN/8-k
- RSS and alerts for SAEN: https://www.quantisnow.com/docs/rss-feeds.md